Showing results (81-90 of 92) with videos related to
Sort By:
Pageof 10
Clinical and Translational Medicine|June 23, 2020
Contrast-enhanced CT radiomics for preoperative evaluation of microvascular invasion in hepatocellular carcinoma: A two-center studyXiuming Zhang, Shijian Ruan, Wenbo Xiao, et al.Hepatology Communications|February 9, 2023
Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trialChengxiang Guo, Junlei Zhang, Xin Huang, et al.Annals of Surgical Oncology|April 13, 2023
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 TrialQihan Fu, Yiwen Chen, Dabing Huang, et al.Annals of Surgery|February 2, 2023
Radical Resection Combined With Intestinal Autotransplantation for Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy: A Report of 36 Consecutive CasesTingbo Liang, Qi Zhang, Guosheng Wu, et al.European Journal of Radiology|October 1, 2025
Radiomic biomarkers for the recurrence prediction of hepatocellular carcinoma treated with postoperative TACE: A multicenter retrospective studyLingling Zhou, Liyun Zheng, Kun Zhang, et al.Cancer Cell|October 10, 2025
Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trialXueli Bai, Xiang Li, Yiwen Chen, et al.Annals of Surgical Oncology|July 18, 2022
Comprehensive Clinical Analysis of Gallbladder Neuroendocrine Neoplasms: A Large-Volume Multicenter Study During One DecadeYangyang Wang, Bingfeng Huang, Qihan Fu, et al.European Journal of Medicinal Chemistry|June 15, 2019
Discovery of 6-(2-(dimethylamino)ethyl)-N-(5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole-6-yl)pyrimidin-2-yl)-5,6,7,8-tetrahydro-1,6-naphthyridin-2-amine as a highly potent cyclin-dependent kinase 4/6 inhibitor for treatment of cancerChen Shi, Qian Wang, Xuemei Liao, et al.BMC Cancer|January 14, 2023
Normalization of tumor markers and a clear resection margin affect progression-free survival of patients with unresectable pancreatic cancer who have undergone conversion surgeryXiang Li, Xinyuan Liu, Na Lu, et al.Journal of Hepatocellular Carcinoma|February 3, 2025
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular CarcinomaWeilang Wang, Qi Zhang, Ying Cui, et al.Pageof 10